# Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol.

> **NCT03942861** · — · UNKNOWN · sponsor: **Copenhagen University Hospital at Herlev** · enrollment: 50 (estimated)

## Conditions studied

- Ulcerative Colitis
- Ultrasound Therapy; Complications

## Interventions

- **DRUG:** Solu-Medrol

## Key facts

- **NCT ID:** NCT03942861
- **Lead sponsor:** Copenhagen University Hospital at Herlev
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-21
- **Primary completion:** 2021-09-21
- **Final completion:** 2022-02-21
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03942861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03942861, "Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03942861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*